Recital 15, Regulation (EU) 2020/762

In forcesince 9 Jun 2020

Article 43 of Regulation (EC) No 1069/2009 stipulates that export of certain Category 1 and 2 materials may be authorised only under harmonised rules. Annex XII as well as Sections 2 and 3 of Chapter II of Annex XIV to Regulation (EU) No 142/2011 provide the conditions under which certain blood, blood products and intermediate products may be imported for the production of final pharmaceutical products or in order to be subject to a particular production step in the manufacturing chain of pharmaceuticals. The export of blood, blood products and intermediate products, which comply with the requirements for the import or placing on the market, should therefore be authorised and the rules for export be established in Chapter V of Annex XIV to Regulation (EU) No 142/2011.